Bridgeway Capital Management LLC Grows Holdings in Select Medical Holdings Corporation $SEM

Key Points

• Bridgeway Capital Management LLC increased its holdings in Select Medical Holdings Corporation by 43.1% in the first quarter, now owning about 1,068,658 shares valued at approximately $17.8 million.
• Select Medical reported earnings of $0.32 EPS for the last quarter, exceeding estimates, with a revenue of $1.34 billion, marking a 4.5% year-over-year growth.
• The company has declared a quarterly dividend of $0.0625, representing an annualized payment of $0.25 and a yield of 1.9%.

Bridgeway Capital Management LLC boosted its position in Select Medical Holdings Corporation (NYSE:SEM - Free Report) by 43.1% in the first quarter, according to its most recent filing with the SEC. The institutional investor owned 1,068,658 shares of the health services provider's stock after purchasing an additional 322,035 shares during the period. Bridgeway Capital Management LLC owned about 0.83% of Select Medical worth $17,847,000 as of its most recent SEC filing.

Several other hedge funds have also recently modified their holdings of SEM. Northern Trust Corp grew its holdings in shares of Select Medical by 12.9% in the fourth quarter. Northern Trust Corp now owns 1,352,046 shares of the health services provider's stock valued at $25,486,000 after acquiring an additional 153,992 shares in the last quarter. Schonfeld Strategic Advisors LLC bought a new position in Select Medical in the 4th quarter valued at $889,000. Comerica Bank increased its position in shares of Select Medical by 19.0% during the 4th quarter. Comerica Bank now owns 75,408 shares of the health services provider's stock valued at $1,421,000 after purchasing an additional 12,020 shares during the last quarter. AXA S.A. bought a new stake in shares of Select Medical during the 4th quarter worth $559,000. Finally, BNP Paribas Financial Markets boosted its holdings in shares of Select Medical by 1,965.5% in the 4th quarter. BNP Paribas Financial Markets now owns 551,912 shares of the health services provider's stock worth $10,404,000 after buying an additional 525,192 shares during the last quarter. Institutional investors own 89.48% of the company's stock.

Select Medical Price Performance

SEM opened at $13.03 on Wednesday. The firm has a 50-day moving average price of $13.78 and a 200-day moving average price of $15.42. Select Medical Holdings Corporation has a twelve month low of $11.65 and a twelve month high of $40.98. The company has a quick ratio of 1.15, a current ratio of 1.15 and a debt-to-equity ratio of 0.92. The company has a market capitalization of $1.62 billion, a price-to-earnings ratio of 12.29, a PEG ratio of 0.53 and a beta of 1.25.

Select Medical (NYSE:SEM - Get Free Report) last released its quarterly earnings data on Thursday, July 31st. The health services provider reported $0.32 EPS for the quarter, topping the consensus estimate of $0.28 by $0.04. Select Medical had a net margin of 2.37% and a return on equity of 8.87%. The company had revenue of $1.34 billion during the quarter, compared to the consensus estimate of $1.35 billion. During the same period last year, the firm earned $0.60 EPS. Select Medical's revenue for the quarter was up 4.5% on a year-over-year basis. Select Medical has set its FY 2025 guidance at 1.090-1.19 EPS. Equities analysts expect that Select Medical Holdings Corporation will post 1.17 EPS for the current year.

Select Medical Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Thursday, August 28th. Stockholders of record on Wednesday, August 13th were given a $0.0625 dividend. The ex-dividend date was Wednesday, August 13th. This represents a $0.25 annualized dividend and a dividend yield of 1.9%. Select Medical's payout ratio is 23.58%.

Analyst Ratings Changes

A number of analysts recently issued reports on SEM shares. Royal Bank Of Canada decreased their price objective on shares of Select Medical from $23.00 to $19.00 and set an "outperform" rating for the company in a report on Wednesday, May 7th. UBS Group restated a "neutral" rating and set a $14.00 price target (down previously from $15.00) on shares of Select Medical in a research note on Monday, August 4th. Three analysts have rated the stock with a Buy rating and one has given a Hold rating to the stock. According to MarketBeat, the stock currently has an average rating of "Moderate Buy" and a consensus price target of $20.25.

About Select Medical

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.